Coronary vascular endothelium-myocyte interactions in protection of the heart by ischaemic preconditioning

Journal of Physiology and Pharmacology

Volumn 50, Issue 4, 1999, Pages 509-524

  Parratt, J R ^a,b   Vegh, A ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF SZEGED   (Hungary)

^c NONE

Author keywords

Bradykinin; Endothelial myocyte interactions; Myocardial protection; Nitric oxite; Preconditioning

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; NITRIC OXIDE; PROSTACYCLIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; RAT; STRESS;

ANIMALS; ARRHYTHMIA; BRADYKININ; CLINICAL TRIALS; ENDOTHELIUM, VASCULAR; HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE;

EID: 0033400259     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Vane JR, Botting RM. Regulatory mechanisms of the vascular endothelium: an update. Pol Journal of Pharmacology 1994; 46: 497-521.
2. Bassenǵe E. Control of coronary blood flow by autacoids. Basic Res Cardiol 1995; 90: 5-41.
3. Gryglewski R, Chlopicki S, Niezabitowski P. Endothelial control of coronary flow in perfused guinea pig heart. Basic Res Cardiol 1995; 90: 119-124.
4. Fatehi-Hassanabad Z, Furman BL, Parratt JR. The effect of endotoxin on sympathetic responses in the rat isolated perfused mesenteric bed; involvement of nitric oxide and cyclo-oxygenase products. Brit J Pharmacol 1995; 116: 3316-3322.
5. Brutsaert DL. The endocardium. Ann Rev Physiol 1989; 51: 263-273.
6. Vegh A, Szekeres L, Parratt JR. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 1992; 107: 648-52.
7. Kaszaki J, Wolfard A, Bari F, Boros M, Parratt JR, Nagy S. Effect of nitric oxide synthase inhibition on myocardial contractility in anaesthetised normal and endotoxemic dogs. Shock 1996; 6: 279-285.
8. Sys SU, Mohan P, Andries LJ, De Keulenaer G, Fransen PF, Brutsaert DL. Endocardial endothelial modulation of myocardial contraction. In: Endothelial Modulation of Cardiac Function, MJ Lewis, AJ Shah (eds). Harwood, Netherlands, 1997, pp. 1-18.
9. Grocott-Mason RM, Anning PB, Lewis MJ, Shah AM. Nitric oxide and myocardial contraction. In: Endothelial Modulation of Cardiac Function, MJ Lewis, AJ Shah (eds). Harwood, Netherlands, 1997, pp. 19-34.
10. Paulus WJ. Nitric oxide and cardiac contraction: Clinical studies. In: Endothelial Modulation of Cardiac Function, MJ Lewis, AJ Shah (eds). Harwood, Netherlands, 1997, pp. 35-52.
11. Li K, Rouleau JL, Andries LJ, Brutsaert DL. Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles. Circ Res 1993; 72: 768-777.
12. Hassanabad ZF, Furman BL, Parratt JR, Aughey E. Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts. Basic Res Cardiol 1998; 93: 241-249.
13. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986; 74: 1124-1136.
14. Richard V, Kaeffer N, Tron C, Thuillez C. Ischaemic preconditioning protects against coronary endothelial dysfunction induced by ischaemia and reperfusion. Circulation 1994; 89: 1254-1261.
15. Bauer B, Simkhovich BZ, Kloner RA, Przyklenk K. Does preconditioning protect the coronary vasculature from subsequent ischaemia/reperfusion injury? Circulation 1993; 88: 659-672.
16. Beresewicz A, Karwatowska-Prokopczuk E, Lewartowski B, Cedro-Ceremuzynska K. A protective role of nitric oxide in isolated ischaemic/reperfused rat heart. Cardiovasc Res 1995; 30: 1001-1008.
17. Komori S, Fujimaki S, Ijili H, Tamura Y, Parratt JR. Inhibitory effect of ischemic preconditioning on ischemic arrhythmias using a rat coronary ligation model. Jpn J Electrocardiol 1990; 10: 774-82.
18. Komori S, Vegh A, Szekeres L, Parratt JR. Preconditioning reduces the severity of ischaemia and reperfusion-induced arrhythmias in both anaesthetised rats and dogs. J Physiol 1990; 423: 16P.
19. Vegh A, Szekeres L, Parratt JR. Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res 1991; 25: 1051-53.
20. Vegh A, Komori S, Szekeres L, Parratt JR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 1992; 26: 487-495.
21. Lawson CS, Avkiran M, Shattock MJ, Coltart DJ, Hearse DJ. Preconditioning and reperfusion arrhythmias in the isolated rat heart: true protection or temporal shift in vulnerability? Cardiovasc Res 1993; 27: 2274-2281.
22. Piacentini L, Wainwright CL, Parratt JR. The antiarrhythmic effect of ischaemic preconditioning in isolated rat hearts involves a pertussis toxin sensitive mechanism. Cardiovasc Res 1993; 27: 674-680.
23. Parratt JR, Vegh A, Papp JGy. Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning - a brief review of the evidence. Canad J Physiol Pharmacol 1995; 73: 837-42.
24. Vegh A, Szekeres L, Parratt JR. Local coronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetised dogs. Br J Pharmacol 1991; 104: 294-295.
25. Vegh A, Papp JGy, Szekeres L, Parratt JR. Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetised dogs. Br J Pharmacol 1993; 110: 18-19.
26. 2 receptors. Br J Pharmacol 1994; 113: 1167-72.
27. Parratt JR, Vegh A, Zeitlin IJ, Ahmed M, Oldroyd K, Kaszala K, Papp JGy. Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning. Am J Cardiol 1997; 80: 124A-131A.
28. Vegh A, Papp JGy, Szekeres L, Parratt JR. The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning. Br J Pharmacol 1992; 107: 910-11.
29. Billman GE. Effect of carbachol and cyclic GMP on susceptibility to ventricular fibrillation. FASEB Journal 1993; 4: 1668-1673.
30. Coker SJ, Parratt JR, Ledingham I McA, Zeitlin IJ. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature 1981; 291: 323-324.
31. Vegh A, Szekeres L, Parratt JR. Protective effects of preconditioning of the ischaemic myocardium involves cyclooxygenase products. Cardiovasc Res 1990; : 1020-22.
32. Kis A, Vegh A, Papp J Gy, Parratt JR. Simultaneous blockade of the cyclooxygenase and L-arginine nitric oxide pathways prevents the antiarrhythmic effects of classical preconditioning. Experimental Cardiol 1997; 2: 112-118.
33. Kuzuya T, Hoshida S, Yamashita N. Delayed effects of sublethal-ischaemia on the acquisition of tolerance to ischaemia. Circulation Res 1993; 72: 1293-99.
34. Vegh A, Papp J Gy, Parratt JR. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 1994; 113: 1081-1082.
35. Kis A, Vegh A, Papp JGy, Parratt JR. Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase. Br J Pharmacol 1999: in press.
36. Kis A, Vegh A, Papp JGy, Parratt JR. Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias - role of nitric oxide. J Molec Cell Cardiol 1999: in press.
37. Zeitlin IJ, Fagbemi SO, Parratt JR. Enzymes in normally perfused and ischaemic dog hearts which release a substance with kinin-like activity. Cardiovasc Res 1989; 23: 91-97.
38. Moshi MJ, Zeitlin IJ, Wainwright CL, Parratt JR. Acid optimum kininogenase in canine myocardium and aorta. Cardiovasc Res 1992; 26: 367-370.
39. Parratt JR, Vegh A. Endothelial cells, nitric oxide and ischaemic preconditioning. Basic Res Cardiol 1996; 90: 27-30.
40. Parratt JR, Vegh A. Delayed protection against ventricular arrhythmias by cardiac pacing. Heart 1997; 78: 423-425.
41. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintz TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1993; 74: 349-53.
42. Mombouli J-V, Nakashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and hyperpolarisation evoked by bradykinin in canine coronary arteries: enhancement by exercise-training. Br J Pharmacol 1996; 117: 413-18.